SlideShare a Scribd company logo
Ointments & Pastes
• Pharmaceutical ointments termed unguents are semisolid systems
that are applied externally, primarily to the skin and also to mucous
membranes.
• Medicated ointments are used for the treatment of infection,
inflammation and pruritus.
• Non-medicated ointments are used as emollients and lubricants.
• Pastes are composed of ointment base that contain a high
concentration of dispersed drug ( > 50% w/w)
• The viscosity of pastes are greater than that of ointments.
Factors determining the choice of ointment base
1. The site of application.
2. The required rate of drug release.
3. The chemical stability of drug.
4. The effect of the therapeutic agent on formulation viscosity.
Types of base for ointments and pastes
1. Hydrocarbon bases.
2. Absorption bases.
3. Water-miscible/removable bases.
4. Water-soluble bases.
Hydrocarbon bases – Paraffins
• Non-aqueous having the properties:
• Emollients , prevents water loss by forming occlusive film
• Excellent retention on the skin.
• Predominantly hydrophobic, so difficult to remove from the skin and also
difficult to be applied on the moist surface.
• Not more than 5% of water could be incorporated with careful mixing.
• Chemically inert.
Hard paraffin, white/yellow soft paraffin, liquid paraffin,
microcrystalline wax.
• Hard paraffin is white or colourless microcrystals wax. Melting point
47 – 65. used to enhance the rheological properties of ointment base.
• White/yellow soft paraffin is semisolid, consists of hydrocarbons
derived from petroleum. Melting point 38 – 60 and can be used as an
ointment base without additional components.
• Liquid paraffin; usually formulated with soft paraffin to achieve the
required viscosity. It requires incorporation of antioxidant.
• Microcrystalline wax ; semisolid used to enhance the viscosity of
ointments and creams. It has greater physical stability and when
provided to liquid paraffin it reduces the bleeding of liquid
component.
Absorption bases
• Contain significant amount of an aqueous phase. May be:
• Non-aqueous formulation to which an aqueous phase may be added to
produce water in oil emulsion ( non-emulsified bases).
• Water in oil emulsions that can facilitate the incorporation of an aqueous
phase without inversion or cracking.
• They are still difficult to be removed by washing.
Non-emulsified bases; lanolin (wool fat), wool alcohols, beeswax.
Water in oil emulsions; hydrous lanolin
• Non-emulsified bases are hydrophobic formulations to which water
may be added. Good spreading properties. They are emollients. They
are composed of 1/ paraffins 2/ a sterol based emulsifying agent.
[lanolin ( wool fat), lanolin alcohols ( wool alcohols) and beeswax].
• Lanolin is mixed with vegetable oil or paraffin to produce an ointment
base that can absorb twice of it weight of water to produce water in
oil emulsion. The usual concentration of lanolin in simple ointment is
5 -10 % w/w.
• Wool alcohols is added to a mixture of hard and soft paraffin to
produce the required consistency. Inclusion of wool alcohol 5% w/w
results in a 300% increase in the concentration of water that may be
incorporated in paraffin bases.
• Bees wax consists of esters of aliphatic alcohols C24 – C36 even
numbers . Combined with paraffins to produce non-emulsified bases.
Absorption bases – water in oil emulsion.
• Excipient used in this ointment base is hydrous lanoline which is a
mixture of lanoline and water 25 -30 %.
• It is incorporated into paraffins and oils that can incorporate the
subsequent addition of aqueous phase.
• Oily cream BP is water in emulsion ointment base that is composed of
wool alcohol and water 50% each.
Water-miscible / removable bases
• Used to form water in oil emulsion for topical application.
• They are able to accommodate large volumes of water ( edema – wounds).
• They are not occlusive.
• Easily to be washed and removed out.
• They are aesthetically pleasing.
BP water-miscible/removable bases:
1. Emulsifying ointment
2. Cetrimide emulsifying ointment.
3. Cetomacrogol emulsifying ointment.
• Each containing liquid paraffin20%, white soft paraffin 50% and
emulsifying wax 30%.
• Types of emulsifying wax:
• Anionic emulsifying wax.
• Non-ionic emulsifying wax.
• Cationic emulsifying wax.
Anionic emulsifying wax:
Composed of :
cetosteryl alcohol 90 gm
Sodium lauryl sulphate 10 gm
Purified water 4 ml
Cationic emulsifying wax:
 Cetosteryl alcohol 900 gm
 Cetrimide 100 gm
Non-ionic emulsifying wax:
Cetosteryl alcohol 800 gm
Cetomacrogol1000 200gm
Water-soluble bases
• They are non-greasy, miscible with the excudates and compatible with
majority of therapeutic agents.
• Prepared by mixing Polyethylene glycol 400 and polyethylene glycol
4000 in a ratio of 60%, 40% respectively then heat and controlled
cooling.
• Used to incorporate solid therapeutic agent.
• Incorporation of 5% or more water will liquidify the base.
• To incorporate up to 25% aqueous phase, PEG 400 may be replaced
by stearyl alcohol.
Additional / alternative solvents
• Liquid silicon: used in barrier ointments due to its water-repellent.
• Vegetable oils: may be used either to replace mineral oils or to enhance
the emollient properties ( arachis oil, cocanut oil).
• Organic esters: isopropyl myristate is used to enhance the spreadability
properties and enhance drug dissolution within the ointment base.
Preservatives
• Ointments / pastes that do not contain water do not require
preservative.
• Preservatives for those containing water:
 Phenol 0.2-0.5%, chlorocresol 0.075 – 0.12%
 Benzoic acid and its salts 0.1 – 0.3%
 Methyl parabens and propyl parabens 0.2 -0.3%
• Concentration should equal or exceed the MIC
Antioxidants
- Lipophilic
- Hydrophilic
Manufacture of ointments & Pastes
• Dispersal of the powdered therapeutic agent into the pre-heated
hydrocarbon base using mechanical mixer.
• Hydrophobic component and hydrophilic components are dissolved
separately in their liquid phases.
• The two phases are maintained at 70 C then mixed together either
simultaneously or by adding the aqueous phase to the non-aqueous
phase.
Lotions
• May be formulated as solution or suspension.
• It contains the therapeutic agent and
+ alcohol as co-solvent and coolant.
+ humectants to retain the moisture on the skin after application (
Glycerol).
+ vehicle purified water with or without buffer.
+ preservative.
+ component to stabilize the suspended therapeutic agents.
Liniments
• Alcohol-based liniment: act as counterirritants and rubefacient causing
reddening of the skin and may act to increase the penetration of the
drug through the skin. This will provide cooling effect; soap liniment.
• Oil-based liniment: employed in conditions of massage. Oil used is
arachis oil and cottonseed oil ; camphor liniment, methyl salicylate
liniment.
• Generally no other excipients are used.
Collodions
• Collodions are solutions of pyroxylin ( nitrated cellulose predominantly
cellulose tetranitrate), castor oil and colophony dissolved in an organic
solvent composed of alcohol and ether. Normally applied to the skin by
brush and after evaporation of the solvent will form occlusive film.
• Collodions may contain therapeutic agents as colliodion and salicylic
acid and collodion.
• Collodion is a solution of pyroxylin in 3 ether + 1 alcohol. This will form
firm film and may render flexible by adding 2% camphor and 3% castor
oil.
• Salicylic acid collodion is a solution of salicylic acid 10% in flexible
collodion and used for the treatment of warts.
Advantages of ointments and pastes
• Spreadability.
• Occlusive
• Lubrication and emollient
• Release of drug
• Hydrophobicity
• Pastes………….porosity
• Pastes opaque
• Stability of drug
• Cooling effect
Disadvantages
• Greasy
• Pastes thick
• Staining
• Liniment not applied to broken skin
• Exuding sites
• Limited solubility of drug in base
• Pastes to hair
Pharmaceutical Gels
• Definition:
Semisolid system in which there is interaction either
physical or covalent between colloidal particles within a
liquid vehicle.
Gels – description
• The vehicle is continuous and interact with the colloidal particles
within the 3 dimensional network formed by the bonds created
between the adjacent particles.
• The vehicle may be aqueous, hydro-alcoholic, alcoholic or nonaqeous.
• Colloidal particles may be dispersed solids; kaolin, bentonite.
• Colloidal particles may be dispersed polymers.
• Xerogels are gels in which the vehicle had been removed leaving a
polymer films.
Main categories of pharmaceutical Gels
Categorization was based in the nature of the three dimensional network
of particles.
• Dispersed solid gels.
• Hydrophilic polymer gels
Dispersed solid gels.
• When dispersed particles undergo flocculation throughout the system, a
continuous solid particle network is established, with the liquid vehicle
dispersed in the void volume between the particles.
• The nature of the interaction between the particles in the network may
be van der Waals e.g Aluminium hydroxide gel .
• OR electrostatic bonding e.g Kaolin, bentonite, Al.Mg silicate.
• The particles exhibit plate-like crystal structure with electronegative
charges at the face and electropositive charges at the edges.
• The bonding strength between the particles is weak which can be
broken by shaking resulting in liberation of individual particles. On
removal of stress the rheological properties return. This recovery is
time-dependent and termed thioxytropy.
Hydrophilic polymer gels
• Dispersion of hydrophilic polymer within appropriate aqueous vehicle.
• There are two types:
1- types 1 gels.
2- type 2 gels.
1- types 1 gels.
• Termed as hydrogel.( type 1 chemical)
• The interaction between the polymer chain is covalent and is mediated by
molecules that cross-link the adjacent chains ( cross-linker).
• Example of a cross-liked hydrogel and monomer is hydroxyethylmethacrylate
and the cross- linker ethyleneglycol dimethacrylate.
• It has the ability to absorb a considerable mass of aqueous fluid whilst still
retaining the3D structure.
• It exhibit robust mechanical structure being resistant to fracture up to 1 kpa.
• Having excellent flexibility
• Hydrogels in which the aqueous been removed is termed xerogels. It is brittle
and the aqueous phase is used as plasticizer.
• Type 1 gels do not exhibit flow when exposed to and applied stress
due to inability of the stress to destroy the covalent bonds.
• This elastic properties enable the energy utilized to be stored and
utilized after removal of stress to return to equilibrium.
• Hydrogels are used in wound dressings, as lubricants coating in
urethral catheters and as soft contact lenses.
• Used for the controlled delivery of therapeutic agents at the site of
implantation.
2- type 2 gels.
• The bonds are either hydrogen bond, ionic association or van der
Waals interactions. These bonds are weaker bonds. So, interactions
between polymer chains are reversible.
• Application of stress can result in flow. So it shear – thinning system.
• Being pseudoplastic, on removal of stress, the intermacromolecules
bonds are reformed.
• This type 2 gels are used in formulations:
- Cellulose derivatives.
- Polysaccharides from natural origin.
- Polyacrylic acid
Cellulose derivatives.
• Methyl cellulose
• Hydroxyethyl cellulose
• Hydroxypropyl cellulose.
• Sodium carboxymethylcellulose.
Polysaccharides from natural origin.
• Carrageenan derived from red seaweed. They are lambda, iota and kappa.
Which differ in the location of sulphate group and absence of
anhydroglactose. Kappa carrageenan exhibit excellent gelling properties. 0.3
– 1% w/w.
• Alginic acid / sodium alginate derived from algae. addition of calcium ions
to aginate solution will result in a viscous gel. It is incompatible with basic
drugs.
• Poly ( acrylic acid); produced following polymerization of acrylic acid and
cross-linking with allyl sucrose or ally ethers of pentaerythritol.0.5 -2% w/w
polyacrylic acid neutralized with an appropriate base is used. It is
incompatible with basic therapeutic agents. Its viscosity is adversely
affected by medium and high concentration of electrolyte.
Factors affecting gelation of type 2 gels
1. Concentration of hydrophilic polymer.
2. Molecular weight of the polymer.
3. Nature of the solvent.
4. pH of the solvent.
5. Ionic strength of the solvent phase.
6. Temperature.
7. Ionic gelation.
Concentration of hydrophilic polymer.
• At low concentrations, the hydrophilic polymer exhibit
Newtonian flow due to the limited number of polymer-polymer
interactions.
• As the concentration increases, the number of polymer-polymer
interactions increases and at a definite concentration, the flow
properties become non-Newtonian --- this the gel point.
• Further increase lead to increase in the junction zones and
increase resistance to applied stress.
• Therefore, the physiochemical and rheological properties of a
pharmaceutical gel may be readily manipulated by altering the
concentration of hydrophilic polymer.
Molecular weight of the polymer
• As the molecular weight of the hydrophilic polymer increases at a
definite concentration, there are a greater number of available sites
on the polymer chains that may engage in the polymer-polymer
interactions.
• As a result the viscosity of the formulation increases.
Nature of the solvent.
• In good solvents, the chains of the polymer exist in the expanded state.
• In poor solvent, the polymer chain exist in coiled state.
• The viscosity of the polymer solution depend on the expansion of the
polymer chains.
• Therefore, the physiochemical properties of the gel are dependent on
the solvent system into which the hydrophilic polymer is dissolved.
• In poor solvents gelation will not occur.
pH of the solvent.
• The pH affects the ionization of acidic or basic polymers which in turn
affects the expansion state of the polymer.
• In non-ionized state, acidic and basic polymers exist in a coiled state
and gelation does not occur.
• The rheological properties of ionic polymers are optimal with range of
pH values at which maximum expansion of chains occur.
• The rheological properties of non-ionic polymers are unaffected by
the pH of the solvent, usually pH 4 – 10.
Ionic strength of the solvent phase.
• Presence of high concentration of electrolytes affects both ionic and
non-ionic polymers.
• Non-ionic polymers may be salted out of solution due to desolvation
of the polymer chains.
• At low concentration of electrolyte , shielding of the charge on the
ionic polymer will occur, this will reduce the capacity of the polymer
to interact with solvent resulting in compromised gel properties.
• If the concentration of the electrolyte is too high, salting out of ionic
polymer will result.
Temperature
• Methyl cellulose and hydroxypropyl cellulose have been reported to
undergo gelation at elevated temperature 50 – 60 ˚C . this transition
has a limited biological relevance.
• Poly(oxyethylene)-poly(oxypropylene)block co-polymers undergo
thermal transition at < 37˚C range. At temperature below this
transition ( sol-gel) temperature Tsol/gel , the solution of the polymer
undergo Newtonian flow and low viscosity ( sol state). Above this
Tsol/gel is converted into gel with pronounced elasticity and viscosity.
• In solution at temperature below Tsol/gel and above the critical micelle
concentration , the polymer exists in a micellar state, elevation of
temperature above Tsol/gel , the micelles aggregate resulting in a gel.
On lowering the temperature will result in deaggregation of micelles
and reemergence of sol.
• This lead to their use as drug delivery system. Within the oral cavity
and rectum.
Ionic gelation
Certain hydrophilic polymers undergo gelation in the presence of
inorganic metal ions.
 Polyvinyl alcohol polymers, gelation occur in the presence of borate ,
permanganate giving a gel of excellent mechanical strength due to
the borate anion-mediated cross-link. ( toy Kid)
 Gelation of alginic acid occur in the presence of Mg, Ca, and Al ions.
Formulation of a pharmaceutical gels
1. Choice vehicle.
2. Inclusion of buffer.
3. Preservatives.
4. Antioxidants.
5. Flavours/ sweetening agents.
6. Colours.
Choice of vehicle
• Purified water is the normally used in formulation of pharmaceutical gel.
 Co-solvent may be used as alcohol, propylene glycol, glycerol, poly
ethylene glycol 400 to enhance the solubility of the therapeutic agent
and to enhance permeation across the skin ( ethanol).
 If the drug has poor chemical stability and/or poor solubility in water,
pharmaceutical gel may be formulated using propylene glycol, glycerol,
polyethylene glycol 400 and poly acrylic acid.
 In these systems gelation is facilitated by hydrogen bonding between
hydroxyl and carboxylic acid groups and this results in:
1. expansion of pendant groups on the polymer chain.
2. Non-covalent cross-linking of adjacent polymer chain.
Inclusion of buffer
• Citrate and phosphate buffer may be included in aquous or
hydroalcoholic gels to control the pH of the formulation.
• The solubility of buffer salts is decreased in hydroalcoholic-based
vehicles.
Preservatives
• Same as ointments.
• It should be noted that parabens, phenolics interacts with the
hydrophilic polymers used to prepare gels, therby reducing the
concentration of free ( antimicrobially active ) preservative. Thus, the
concentration of these preservatives should be increased.
Antioxidants
• Used to increase the chemical stability that are prone to oxidative
degradation.
• Selection of antioxidant depend on the nature of the vehicle used.
• Because majority of gels are aquous-based, water-soluble
antioxoidant is used.( sodium metabisuphite, sodium formaldehyde
sulphoxylate are commonly used)
Flavours/ sweetening / coluring agents
• Refer to solutions.
Manufacturing of pharmaceutical gels
• Water soluble components are dissolved in the vehicle in a mixing
vessel with mechanical stirring.
• The hydrophilic polymer is added to the stirring mixture slowly to
prevent aggregation.
• Stirring is continued until complete dissolution of the polymer.
• Excessive stirring results in entrapment of air.
• Vacuum may be applied to remove the entrapped air.

More Related Content

What's hot

Ophthalmic Preparation
Ophthalmic PreparationOphthalmic Preparation
Ophthalmic Preparation
Prashant Bhagwan Patil
 
Ophthalmic preparations
Ophthalmic preparationsOphthalmic preparations
Ophthalmic preparations
Srikanth Avn
 
Opthalmic dosage form with description
Opthalmic dosage form with descriptionOpthalmic dosage form with description
Opthalmic dosage form with description
VARSHAAWASAR
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
Liesl Brown
 
Industrial Pharmacy-I -Ophthalmic preparation part 3
Industrial Pharmacy-I -Ophthalmic preparation part 3Industrial Pharmacy-I -Ophthalmic preparation part 3
Industrial Pharmacy-I -Ophthalmic preparation part 3
SureshKumar3824
 
Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)
Anil Deore
 
OTC Eye Products
OTC Eye Products OTC Eye Products
OTC Eye Products
Ahmad AlJifri
 
dr.deepthikolluru avancements in Ophthalmic products ppt
dr.deepthikolluru avancements in Ophthalmic products pptdr.deepthikolluru avancements in Ophthalmic products ppt
dr.deepthikolluru avancements in Ophthalmic products ppt
DeepthiKolluru1
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
Deepak Sarangi
 
Ophthalmic dosage form: eye drops & ointment
Ophthalmic dosage form: eye drops & ointmentOphthalmic dosage form: eye drops & ointment
Ophthalmic dosage form: eye drops & ointment
himanshu dhawan
 
Industrial Pharmacy- I Ophthalmic preparation part 2
Industrial Pharmacy- I Ophthalmic preparation part 2Industrial Pharmacy- I Ophthalmic preparation part 2
Industrial Pharmacy- I Ophthalmic preparation part 2
SureshKumar3824
 
Aerosol
AerosolAerosol
Ophthalmic preparation
Ophthalmic preparationOphthalmic preparation
Ophthalmic preparation
Ravish Yadav
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
Liesl Brown
 
ocular drug delivary system.....
ocular drug delivary system.....ocular drug delivary system.....
ocular drug delivary system.....
dushyant kumar dewangan
 
Opthalmic drug delivery
Opthalmic drug deliveryOpthalmic drug delivery
Opthalmic drug delivery
Paul James Alava
 
Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert
Ra'Fat Ala'taby
 
Special solution-and-suspension
Special solution-and-suspensionSpecial solution-and-suspension
Special solution-and-suspension
Cristina Joy Reyes
 
A 1
A 1A 1

What's hot (20)

Ophthalmic Preparation
Ophthalmic PreparationOphthalmic Preparation
Ophthalmic Preparation
 
Ophthalmic preparations
Ophthalmic preparationsOphthalmic preparations
Ophthalmic preparations
 
Opthalmic dosage form with description
Opthalmic dosage form with descriptionOpthalmic dosage form with description
Opthalmic dosage form with description
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
 
Industrial Pharmacy-I -Ophthalmic preparation part 3
Industrial Pharmacy-I -Ophthalmic preparation part 3Industrial Pharmacy-I -Ophthalmic preparation part 3
Industrial Pharmacy-I -Ophthalmic preparation part 3
 
Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)Sterile dosage form (opthalmic)
Sterile dosage form (opthalmic)
 
OTC Eye Products
OTC Eye Products OTC Eye Products
OTC Eye Products
 
dr.deepthikolluru avancements in Ophthalmic products ppt
dr.deepthikolluru avancements in Ophthalmic products pptdr.deepthikolluru avancements in Ophthalmic products ppt
dr.deepthikolluru avancements in Ophthalmic products ppt
 
Opthalmic products
Opthalmic productsOpthalmic products
Opthalmic products
 
Ophthalmic dosage form: eye drops & ointment
Ophthalmic dosage form: eye drops & ointmentOphthalmic dosage form: eye drops & ointment
Ophthalmic dosage form: eye drops & ointment
 
Industrial Pharmacy- I Ophthalmic preparation part 2
Industrial Pharmacy- I Ophthalmic preparation part 2Industrial Pharmacy- I Ophthalmic preparation part 2
Industrial Pharmacy- I Ophthalmic preparation part 2
 
Aerosol
AerosolAerosol
Aerosol
 
Ophthalmic preparation
Ophthalmic preparationOphthalmic preparation
Ophthalmic preparation
 
Eye, Ear And Nose Formulations
Eye, Ear And Nose FormulationsEye, Ear And Nose Formulations
Eye, Ear And Nose Formulations
 
Opthalmic preparation
Opthalmic preparationOpthalmic preparation
Opthalmic preparation
 
ocular drug delivary system.....
ocular drug delivary system.....ocular drug delivary system.....
ocular drug delivary system.....
 
Opthalmic drug delivery
Opthalmic drug deliveryOpthalmic drug delivery
Opthalmic drug delivery
 
Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert Bioadhesive ophthalmic drug insert
Bioadhesive ophthalmic drug insert
 
Special solution-and-suspension
Special solution-and-suspensionSpecial solution-and-suspension
Special solution-and-suspension
 
A 1
A 1A 1
A 1
 

Similar to Ointments &amp; pastes

semisoliddosageformfordiploma-180924113501-1.pdf
semisoliddosageformfordiploma-180924113501-1.pdfsemisoliddosageformfordiploma-180924113501-1.pdf
semisoliddosageformfordiploma-180924113501-1.pdf
SaqibTeli1
 
Semisolid dosage -Ointments, Pate,Jellies
Semisolid dosage -Ointments, Pate,JelliesSemisolid dosage -Ointments, Pate,Jellies
Semisolid dosage -Ointments, Pate,Jellies
Ravikumar Patil
 
Chapter 10 DDS SEMISOLIDS
Chapter 10 DDS SEMISOLIDSChapter 10 DDS SEMISOLIDS
Chapter 10 DDS SEMISOLIDS
Val Villalon
 
20120507-semisolid-dosage-form.ppt
20120507-semisolid-dosage-form.ppt20120507-semisolid-dosage-form.ppt
20120507-semisolid-dosage-form.ppt
Pratik Singh
 
Semi solid dosage forms
Semi solid dosage formsSemi solid dosage forms
Semi solid dosage forms
Iqra Zulfiqar Ali Rajput
 
skin creams.pptx
skin creams.pptxskin creams.pptx
skin creams.pptx
Nagaraju772087
 
lecture 5.pdf
lecture 5.pdflecture 5.pdf
lecture 5.pdf
HebaYassin10
 
Pharmaceutical emulsion
Pharmaceutical emulsionPharmaceutical emulsion
Pharmaceutical emulsion
Banaras Hindu University
 
semisoliddosageformfordiploma-180924113501-1.pptx
semisoliddosageformfordiploma-180924113501-1.pptxsemisoliddosageformfordiploma-180924113501-1.pptx
semisoliddosageformfordiploma-180924113501-1.pptx
VaishaliThakkar10
 
Semi solid ppt
Semi solid pptSemi solid ppt
Semi solid ppt
devender1002
 
emulsion.pptx, pharmacy students material
emulsion.pptx, pharmacy students materialemulsion.pptx, pharmacy students material
emulsion.pptx, pharmacy students material
Eyasu44
 
Pharmaceuticals 2 / Creams explained .pdf
Pharmaceuticals 2 / Creams explained .pdfPharmaceuticals 2 / Creams explained .pdf
Pharmaceuticals 2 / Creams explained .pdf
mr0780364411
 
Unit V Semisolid Dosage Forms.pdf
Unit V Semisolid Dosage Forms.pdfUnit V Semisolid Dosage Forms.pdf
Unit V Semisolid Dosage Forms.pdf
Gaurav Patil
 
emulsion
 emulsion emulsion
emulsion
Ravikumar Patil
 
Semi solid dosage forms
Semi solid dosage formsSemi solid dosage forms
Semi solid dosage forms
SaqibShaik2
 
Emulsion
EmulsionEmulsion
Emollient and rheological additives
Emollient and rheological additivesEmollient and rheological additives
Emollient and rheological additives
Priya Mathuria
 
Vehicles and Formulations in Dermatology
Vehicles and Formulations in DermatologyVehicles and Formulations in Dermatology
Vehicles and Formulations in Dermatology
NishkarshChugh
 
Cosmetics.pdf
Cosmetics.pdfCosmetics.pdf
Cosmetics.pdf
BALASUNDARESAN M
 

Similar to Ointments &amp; pastes (20)

semisoliddosageformfordiploma-180924113501-1.pdf
semisoliddosageformfordiploma-180924113501-1.pdfsemisoliddosageformfordiploma-180924113501-1.pdf
semisoliddosageformfordiploma-180924113501-1.pdf
 
Semisolid dosage -Ointments, Pate,Jellies
Semisolid dosage -Ointments, Pate,JelliesSemisolid dosage -Ointments, Pate,Jellies
Semisolid dosage -Ointments, Pate,Jellies
 
Chapter 10 DDS SEMISOLIDS
Chapter 10 DDS SEMISOLIDSChapter 10 DDS SEMISOLIDS
Chapter 10 DDS SEMISOLIDS
 
20120507-semisolid-dosage-form.ppt
20120507-semisolid-dosage-form.ppt20120507-semisolid-dosage-form.ppt
20120507-semisolid-dosage-form.ppt
 
Semi solid dosage forms
Semi solid dosage formsSemi solid dosage forms
Semi solid dosage forms
 
skin creams.pptx
skin creams.pptxskin creams.pptx
skin creams.pptx
 
lecture 5.pdf
lecture 5.pdflecture 5.pdf
lecture 5.pdf
 
Pharmaceutical emulsion
Pharmaceutical emulsionPharmaceutical emulsion
Pharmaceutical emulsion
 
semisoliddosageformfordiploma-180924113501-1.pptx
semisoliddosageformfordiploma-180924113501-1.pptxsemisoliddosageformfordiploma-180924113501-1.pptx
semisoliddosageformfordiploma-180924113501-1.pptx
 
Semi solid ppt
Semi solid pptSemi solid ppt
Semi solid ppt
 
emulsion.pptx, pharmacy students material
emulsion.pptx, pharmacy students materialemulsion.pptx, pharmacy students material
emulsion.pptx, pharmacy students material
 
Pharmaceuticals 2 / Creams explained .pdf
Pharmaceuticals 2 / Creams explained .pdfPharmaceuticals 2 / Creams explained .pdf
Pharmaceuticals 2 / Creams explained .pdf
 
Unit V Semisolid Dosage Forms.pdf
Unit V Semisolid Dosage Forms.pdfUnit V Semisolid Dosage Forms.pdf
Unit V Semisolid Dosage Forms.pdf
 
emulsion
 emulsion emulsion
emulsion
 
Emulsions
EmulsionsEmulsions
Emulsions
 
Semi solid dosage forms
Semi solid dosage formsSemi solid dosage forms
Semi solid dosage forms
 
Emulsion
EmulsionEmulsion
Emulsion
 
Emollient and rheological additives
Emollient and rheological additivesEmollient and rheological additives
Emollient and rheological additives
 
Vehicles and Formulations in Dermatology
Vehicles and Formulations in DermatologyVehicles and Formulations in Dermatology
Vehicles and Formulations in Dermatology
 
Cosmetics.pdf
Cosmetics.pdfCosmetics.pdf
Cosmetics.pdf
 

More from Abd Rhman Gamil gamil

Emulsions.pptx
Emulsions.pptxEmulsions.pptx
Emulsions.pptx
Abd Rhman Gamil gamil
 
Respiratory dosage form technology
Respiratory dosage form technologyRespiratory dosage form technology
Respiratory dosage form technology
Abd Rhman Gamil gamil
 
Rectal &amp; vaginal
Rectal &amp; vaginalRectal &amp; vaginal
Rectal &amp; vaginal
Abd Rhman Gamil gamil
 
Tablet technology
Tablet technologyTablet technology
Tablet technology
Abd Rhman Gamil gamil
 
Principles of good manufacturing practice
Principles of good manufacturing practicePrinciples of good manufacturing practice
Principles of good manufacturing practice
Abd Rhman Gamil gamil
 
Good storage practices for pharmaceuticals
Good storage practices for pharmaceuticalsGood storage practices for pharmaceuticals
Good storage practices for pharmaceuticals
Abd Rhman Gamil gamil
 
Hospital &; community
Hospital &; community Hospital &; community
Hospital &; community
Abd Rhman Gamil gamil
 
Ointments &pastes
Ointments &pastesOintments &pastes
Ointments &pastes
Abd Rhman Gamil gamil
 
Oral liquid dosage form technology
Oral liquid dosage form technologyOral liquid dosage form technology
Oral liquid dosage form technology
Abd Rhman Gamil gamil
 
Novel&amp; nano drug delivery systems
Novel&amp; nano drug delivery systemsNovel&amp; nano drug delivery systems
Novel&amp; nano drug delivery systems
Abd Rhman Gamil gamil
 
Parenteral products
Parenteral productsParenteral products
Parenteral products
Abd Rhman Gamil gamil
 
Capsule technology [autosaved]
Capsule technology [autosaved]Capsule technology [autosaved]
Capsule technology [autosaved]
Abd Rhman Gamil gamil
 
Tablet manufacturing tech
Tablet manufacturing techTablet manufacturing tech
Tablet manufacturing tech
Abd Rhman Gamil gamil
 
Pharmacy practice
Pharmacy practicePharmacy practice
Pharmacy practice
Abd Rhman Gamil gamil
 

More from Abd Rhman Gamil gamil (15)

Emulsions.pptx
Emulsions.pptxEmulsions.pptx
Emulsions.pptx
 
Respiratory dosage form technology
Respiratory dosage form technologyRespiratory dosage form technology
Respiratory dosage form technology
 
Rectal &amp; vaginal
Rectal &amp; vaginalRectal &amp; vaginal
Rectal &amp; vaginal
 
Tablet technology
Tablet technologyTablet technology
Tablet technology
 
OTC lectures
OTC lecturesOTC lectures
OTC lectures
 
Principles of good manufacturing practice
Principles of good manufacturing practicePrinciples of good manufacturing practice
Principles of good manufacturing practice
 
Good storage practices for pharmaceuticals
Good storage practices for pharmaceuticalsGood storage practices for pharmaceuticals
Good storage practices for pharmaceuticals
 
Hospital &; community
Hospital &; community Hospital &; community
Hospital &; community
 
Ointments &pastes
Ointments &pastesOintments &pastes
Ointments &pastes
 
Oral liquid dosage form technology
Oral liquid dosage form technologyOral liquid dosage form technology
Oral liquid dosage form technology
 
Novel&amp; nano drug delivery systems
Novel&amp; nano drug delivery systemsNovel&amp; nano drug delivery systems
Novel&amp; nano drug delivery systems
 
Parenteral products
Parenteral productsParenteral products
Parenteral products
 
Capsule technology [autosaved]
Capsule technology [autosaved]Capsule technology [autosaved]
Capsule technology [autosaved]
 
Tablet manufacturing tech
Tablet manufacturing techTablet manufacturing tech
Tablet manufacturing tech
 
Pharmacy practice
Pharmacy practicePharmacy practice
Pharmacy practice
 

Recently uploaded

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
Peter Windle
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Atul Kumar Singh
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
kaushalkr1407
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
Special education needs
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
EugeneSaldivar
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
Jheel Barad
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Po-Chuan Chen
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
vaibhavrinwa19
 

Recently uploaded (20)

Embracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic ImperativeEmbracing GenAI - A Strategic Imperative
Embracing GenAI - A Strategic Imperative
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 
2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
Guidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th SemesterGuidance_and_Counselling.pdf B.Ed. 4th Semester
Guidance_and_Counselling.pdf B.Ed. 4th Semester
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
The Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdfThe Roman Empire A Historical Colossus.pdf
The Roman Empire A Historical Colossus.pdf
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
special B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdfspecial B.ed 2nd year old paper_20240531.pdf
special B.ed 2nd year old paper_20240531.pdf
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...TESDA TM1 REVIEWER  FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
TESDA TM1 REVIEWER FOR NATIONAL ASSESSMENT WRITTEN AND ORAL QUESTIONS WITH A...
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Instructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptxInstructions for Submissions thorugh G- Classroom.pptx
Instructions for Submissions thorugh G- Classroom.pptx
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdfAdversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
Adversarial Attention Modeling for Multi-dimensional Emotion Regression.pdf
 
Acetabularia Information For Class 9 .docx
Acetabularia Information For Class 9  .docxAcetabularia Information For Class 9  .docx
Acetabularia Information For Class 9 .docx
 

Ointments &amp; pastes

  • 1. Ointments & Pastes • Pharmaceutical ointments termed unguents are semisolid systems that are applied externally, primarily to the skin and also to mucous membranes. • Medicated ointments are used for the treatment of infection, inflammation and pruritus. • Non-medicated ointments are used as emollients and lubricants. • Pastes are composed of ointment base that contain a high concentration of dispersed drug ( > 50% w/w) • The viscosity of pastes are greater than that of ointments.
  • 2. Factors determining the choice of ointment base 1. The site of application. 2. The required rate of drug release. 3. The chemical stability of drug. 4. The effect of the therapeutic agent on formulation viscosity.
  • 3. Types of base for ointments and pastes 1. Hydrocarbon bases. 2. Absorption bases. 3. Water-miscible/removable bases. 4. Water-soluble bases.
  • 4. Hydrocarbon bases – Paraffins • Non-aqueous having the properties: • Emollients , prevents water loss by forming occlusive film • Excellent retention on the skin. • Predominantly hydrophobic, so difficult to remove from the skin and also difficult to be applied on the moist surface. • Not more than 5% of water could be incorporated with careful mixing. • Chemically inert. Hard paraffin, white/yellow soft paraffin, liquid paraffin, microcrystalline wax.
  • 5. • Hard paraffin is white or colourless microcrystals wax. Melting point 47 – 65. used to enhance the rheological properties of ointment base. • White/yellow soft paraffin is semisolid, consists of hydrocarbons derived from petroleum. Melting point 38 – 60 and can be used as an ointment base without additional components. • Liquid paraffin; usually formulated with soft paraffin to achieve the required viscosity. It requires incorporation of antioxidant. • Microcrystalline wax ; semisolid used to enhance the viscosity of ointments and creams. It has greater physical stability and when provided to liquid paraffin it reduces the bleeding of liquid component.
  • 6. Absorption bases • Contain significant amount of an aqueous phase. May be: • Non-aqueous formulation to which an aqueous phase may be added to produce water in oil emulsion ( non-emulsified bases). • Water in oil emulsions that can facilitate the incorporation of an aqueous phase without inversion or cracking. • They are still difficult to be removed by washing. Non-emulsified bases; lanolin (wool fat), wool alcohols, beeswax. Water in oil emulsions; hydrous lanolin
  • 7. • Non-emulsified bases are hydrophobic formulations to which water may be added. Good spreading properties. They are emollients. They are composed of 1/ paraffins 2/ a sterol based emulsifying agent. [lanolin ( wool fat), lanolin alcohols ( wool alcohols) and beeswax]. • Lanolin is mixed with vegetable oil or paraffin to produce an ointment base that can absorb twice of it weight of water to produce water in oil emulsion. The usual concentration of lanolin in simple ointment is 5 -10 % w/w. • Wool alcohols is added to a mixture of hard and soft paraffin to produce the required consistency. Inclusion of wool alcohol 5% w/w results in a 300% increase in the concentration of water that may be incorporated in paraffin bases. • Bees wax consists of esters of aliphatic alcohols C24 – C36 even numbers . Combined with paraffins to produce non-emulsified bases.
  • 8. Absorption bases – water in oil emulsion. • Excipient used in this ointment base is hydrous lanoline which is a mixture of lanoline and water 25 -30 %. • It is incorporated into paraffins and oils that can incorporate the subsequent addition of aqueous phase. • Oily cream BP is water in emulsion ointment base that is composed of wool alcohol and water 50% each.
  • 9. Water-miscible / removable bases • Used to form water in oil emulsion for topical application. • They are able to accommodate large volumes of water ( edema – wounds). • They are not occlusive. • Easily to be washed and removed out. • They are aesthetically pleasing.
  • 10. BP water-miscible/removable bases: 1. Emulsifying ointment 2. Cetrimide emulsifying ointment. 3. Cetomacrogol emulsifying ointment. • Each containing liquid paraffin20%, white soft paraffin 50% and emulsifying wax 30%. • Types of emulsifying wax: • Anionic emulsifying wax. • Non-ionic emulsifying wax. • Cationic emulsifying wax.
  • 11. Anionic emulsifying wax: Composed of : cetosteryl alcohol 90 gm Sodium lauryl sulphate 10 gm Purified water 4 ml Cationic emulsifying wax:  Cetosteryl alcohol 900 gm  Cetrimide 100 gm Non-ionic emulsifying wax: Cetosteryl alcohol 800 gm Cetomacrogol1000 200gm
  • 12. Water-soluble bases • They are non-greasy, miscible with the excudates and compatible with majority of therapeutic agents. • Prepared by mixing Polyethylene glycol 400 and polyethylene glycol 4000 in a ratio of 60%, 40% respectively then heat and controlled cooling. • Used to incorporate solid therapeutic agent. • Incorporation of 5% or more water will liquidify the base. • To incorporate up to 25% aqueous phase, PEG 400 may be replaced by stearyl alcohol.
  • 13. Additional / alternative solvents • Liquid silicon: used in barrier ointments due to its water-repellent. • Vegetable oils: may be used either to replace mineral oils or to enhance the emollient properties ( arachis oil, cocanut oil). • Organic esters: isopropyl myristate is used to enhance the spreadability properties and enhance drug dissolution within the ointment base.
  • 14. Preservatives • Ointments / pastes that do not contain water do not require preservative. • Preservatives for those containing water:  Phenol 0.2-0.5%, chlorocresol 0.075 – 0.12%  Benzoic acid and its salts 0.1 – 0.3%  Methyl parabens and propyl parabens 0.2 -0.3% • Concentration should equal or exceed the MIC Antioxidants - Lipophilic - Hydrophilic
  • 15. Manufacture of ointments & Pastes • Dispersal of the powdered therapeutic agent into the pre-heated hydrocarbon base using mechanical mixer. • Hydrophobic component and hydrophilic components are dissolved separately in their liquid phases. • The two phases are maintained at 70 C then mixed together either simultaneously or by adding the aqueous phase to the non-aqueous phase.
  • 16. Lotions • May be formulated as solution or suspension. • It contains the therapeutic agent and + alcohol as co-solvent and coolant. + humectants to retain the moisture on the skin after application ( Glycerol). + vehicle purified water with or without buffer. + preservative. + component to stabilize the suspended therapeutic agents.
  • 17. Liniments • Alcohol-based liniment: act as counterirritants and rubefacient causing reddening of the skin and may act to increase the penetration of the drug through the skin. This will provide cooling effect; soap liniment. • Oil-based liniment: employed in conditions of massage. Oil used is arachis oil and cottonseed oil ; camphor liniment, methyl salicylate liniment. • Generally no other excipients are used.
  • 18. Collodions • Collodions are solutions of pyroxylin ( nitrated cellulose predominantly cellulose tetranitrate), castor oil and colophony dissolved in an organic solvent composed of alcohol and ether. Normally applied to the skin by brush and after evaporation of the solvent will form occlusive film. • Collodions may contain therapeutic agents as colliodion and salicylic acid and collodion. • Collodion is a solution of pyroxylin in 3 ether + 1 alcohol. This will form firm film and may render flexible by adding 2% camphor and 3% castor oil. • Salicylic acid collodion is a solution of salicylic acid 10% in flexible collodion and used for the treatment of warts.
  • 19. Advantages of ointments and pastes • Spreadability. • Occlusive • Lubrication and emollient • Release of drug • Hydrophobicity • Pastes………….porosity • Pastes opaque • Stability of drug • Cooling effect
  • 20. Disadvantages • Greasy • Pastes thick • Staining • Liniment not applied to broken skin • Exuding sites • Limited solubility of drug in base • Pastes to hair
  • 21. Pharmaceutical Gels • Definition: Semisolid system in which there is interaction either physical or covalent between colloidal particles within a liquid vehicle.
  • 22. Gels – description • The vehicle is continuous and interact with the colloidal particles within the 3 dimensional network formed by the bonds created between the adjacent particles. • The vehicle may be aqueous, hydro-alcoholic, alcoholic or nonaqeous. • Colloidal particles may be dispersed solids; kaolin, bentonite. • Colloidal particles may be dispersed polymers. • Xerogels are gels in which the vehicle had been removed leaving a polymer films.
  • 23. Main categories of pharmaceutical Gels Categorization was based in the nature of the three dimensional network of particles. • Dispersed solid gels. • Hydrophilic polymer gels
  • 24. Dispersed solid gels. • When dispersed particles undergo flocculation throughout the system, a continuous solid particle network is established, with the liquid vehicle dispersed in the void volume between the particles. • The nature of the interaction between the particles in the network may be van der Waals e.g Aluminium hydroxide gel . • OR electrostatic bonding e.g Kaolin, bentonite, Al.Mg silicate. • The particles exhibit plate-like crystal structure with electronegative charges at the face and electropositive charges at the edges. • The bonding strength between the particles is weak which can be broken by shaking resulting in liberation of individual particles. On removal of stress the rheological properties return. This recovery is time-dependent and termed thioxytropy.
  • 25. Hydrophilic polymer gels • Dispersion of hydrophilic polymer within appropriate aqueous vehicle. • There are two types: 1- types 1 gels. 2- type 2 gels.
  • 26. 1- types 1 gels. • Termed as hydrogel.( type 1 chemical) • The interaction between the polymer chain is covalent and is mediated by molecules that cross-link the adjacent chains ( cross-linker). • Example of a cross-liked hydrogel and monomer is hydroxyethylmethacrylate and the cross- linker ethyleneglycol dimethacrylate. • It has the ability to absorb a considerable mass of aqueous fluid whilst still retaining the3D structure. • It exhibit robust mechanical structure being resistant to fracture up to 1 kpa. • Having excellent flexibility • Hydrogels in which the aqueous been removed is termed xerogels. It is brittle and the aqueous phase is used as plasticizer.
  • 27. • Type 1 gels do not exhibit flow when exposed to and applied stress due to inability of the stress to destroy the covalent bonds. • This elastic properties enable the energy utilized to be stored and utilized after removal of stress to return to equilibrium. • Hydrogels are used in wound dressings, as lubricants coating in urethral catheters and as soft contact lenses. • Used for the controlled delivery of therapeutic agents at the site of implantation.
  • 28. 2- type 2 gels. • The bonds are either hydrogen bond, ionic association or van der Waals interactions. These bonds are weaker bonds. So, interactions between polymer chains are reversible. • Application of stress can result in flow. So it shear – thinning system. • Being pseudoplastic, on removal of stress, the intermacromolecules bonds are reformed. • This type 2 gels are used in formulations: - Cellulose derivatives. - Polysaccharides from natural origin. - Polyacrylic acid
  • 29. Cellulose derivatives. • Methyl cellulose • Hydroxyethyl cellulose • Hydroxypropyl cellulose. • Sodium carboxymethylcellulose.
  • 30. Polysaccharides from natural origin. • Carrageenan derived from red seaweed. They are lambda, iota and kappa. Which differ in the location of sulphate group and absence of anhydroglactose. Kappa carrageenan exhibit excellent gelling properties. 0.3 – 1% w/w. • Alginic acid / sodium alginate derived from algae. addition of calcium ions to aginate solution will result in a viscous gel. It is incompatible with basic drugs. • Poly ( acrylic acid); produced following polymerization of acrylic acid and cross-linking with allyl sucrose or ally ethers of pentaerythritol.0.5 -2% w/w polyacrylic acid neutralized with an appropriate base is used. It is incompatible with basic therapeutic agents. Its viscosity is adversely affected by medium and high concentration of electrolyte.
  • 31. Factors affecting gelation of type 2 gels 1. Concentration of hydrophilic polymer. 2. Molecular weight of the polymer. 3. Nature of the solvent. 4. pH of the solvent. 5. Ionic strength of the solvent phase. 6. Temperature. 7. Ionic gelation.
  • 32. Concentration of hydrophilic polymer. • At low concentrations, the hydrophilic polymer exhibit Newtonian flow due to the limited number of polymer-polymer interactions. • As the concentration increases, the number of polymer-polymer interactions increases and at a definite concentration, the flow properties become non-Newtonian --- this the gel point. • Further increase lead to increase in the junction zones and increase resistance to applied stress. • Therefore, the physiochemical and rheological properties of a pharmaceutical gel may be readily manipulated by altering the concentration of hydrophilic polymer.
  • 33. Molecular weight of the polymer • As the molecular weight of the hydrophilic polymer increases at a definite concentration, there are a greater number of available sites on the polymer chains that may engage in the polymer-polymer interactions. • As a result the viscosity of the formulation increases.
  • 34. Nature of the solvent. • In good solvents, the chains of the polymer exist in the expanded state. • In poor solvent, the polymer chain exist in coiled state. • The viscosity of the polymer solution depend on the expansion of the polymer chains. • Therefore, the physiochemical properties of the gel are dependent on the solvent system into which the hydrophilic polymer is dissolved. • In poor solvents gelation will not occur.
  • 35. pH of the solvent. • The pH affects the ionization of acidic or basic polymers which in turn affects the expansion state of the polymer. • In non-ionized state, acidic and basic polymers exist in a coiled state and gelation does not occur. • The rheological properties of ionic polymers are optimal with range of pH values at which maximum expansion of chains occur. • The rheological properties of non-ionic polymers are unaffected by the pH of the solvent, usually pH 4 – 10.
  • 36. Ionic strength of the solvent phase. • Presence of high concentration of electrolytes affects both ionic and non-ionic polymers. • Non-ionic polymers may be salted out of solution due to desolvation of the polymer chains. • At low concentration of electrolyte , shielding of the charge on the ionic polymer will occur, this will reduce the capacity of the polymer to interact with solvent resulting in compromised gel properties. • If the concentration of the electrolyte is too high, salting out of ionic polymer will result.
  • 37. Temperature • Methyl cellulose and hydroxypropyl cellulose have been reported to undergo gelation at elevated temperature 50 – 60 ˚C . this transition has a limited biological relevance. • Poly(oxyethylene)-poly(oxypropylene)block co-polymers undergo thermal transition at < 37˚C range. At temperature below this transition ( sol-gel) temperature Tsol/gel , the solution of the polymer undergo Newtonian flow and low viscosity ( sol state). Above this Tsol/gel is converted into gel with pronounced elasticity and viscosity. • In solution at temperature below Tsol/gel and above the critical micelle concentration , the polymer exists in a micellar state, elevation of temperature above Tsol/gel , the micelles aggregate resulting in a gel. On lowering the temperature will result in deaggregation of micelles and reemergence of sol. • This lead to their use as drug delivery system. Within the oral cavity and rectum.
  • 38. Ionic gelation Certain hydrophilic polymers undergo gelation in the presence of inorganic metal ions.  Polyvinyl alcohol polymers, gelation occur in the presence of borate , permanganate giving a gel of excellent mechanical strength due to the borate anion-mediated cross-link. ( toy Kid)  Gelation of alginic acid occur in the presence of Mg, Ca, and Al ions.
  • 39. Formulation of a pharmaceutical gels 1. Choice vehicle. 2. Inclusion of buffer. 3. Preservatives. 4. Antioxidants. 5. Flavours/ sweetening agents. 6. Colours.
  • 40. Choice of vehicle • Purified water is the normally used in formulation of pharmaceutical gel.  Co-solvent may be used as alcohol, propylene glycol, glycerol, poly ethylene glycol 400 to enhance the solubility of the therapeutic agent and to enhance permeation across the skin ( ethanol).  If the drug has poor chemical stability and/or poor solubility in water, pharmaceutical gel may be formulated using propylene glycol, glycerol, polyethylene glycol 400 and poly acrylic acid.  In these systems gelation is facilitated by hydrogen bonding between hydroxyl and carboxylic acid groups and this results in: 1. expansion of pendant groups on the polymer chain. 2. Non-covalent cross-linking of adjacent polymer chain.
  • 41. Inclusion of buffer • Citrate and phosphate buffer may be included in aquous or hydroalcoholic gels to control the pH of the formulation. • The solubility of buffer salts is decreased in hydroalcoholic-based vehicles.
  • 42. Preservatives • Same as ointments. • It should be noted that parabens, phenolics interacts with the hydrophilic polymers used to prepare gels, therby reducing the concentration of free ( antimicrobially active ) preservative. Thus, the concentration of these preservatives should be increased.
  • 43. Antioxidants • Used to increase the chemical stability that are prone to oxidative degradation. • Selection of antioxidant depend on the nature of the vehicle used. • Because majority of gels are aquous-based, water-soluble antioxoidant is used.( sodium metabisuphite, sodium formaldehyde sulphoxylate are commonly used)
  • 44. Flavours/ sweetening / coluring agents • Refer to solutions.
  • 45. Manufacturing of pharmaceutical gels • Water soluble components are dissolved in the vehicle in a mixing vessel with mechanical stirring. • The hydrophilic polymer is added to the stirring mixture slowly to prevent aggregation. • Stirring is continued until complete dissolution of the polymer. • Excessive stirring results in entrapment of air. • Vacuum may be applied to remove the entrapped air.